|
PCAS BioMatrix signed a world wide licence agreement with Matrix Innovation for the manufacturing and the commercialization of the ChemMatrix® resin.
Located in Quebec, Canada, Matrix Innovation is specialized in the development of Polyethylene Glycol (PEG) resins used in peptide synthesis.
PCAS group, is a leading Fine Chemical company, operating 8 chemical plants in Europe & North America. PCAS offers world-class services related to process development and manufacturing of high added-value molecules or molecules of a strong technological content from kilo-labs to tons scale for industrial companies. Taking advantage of nearly 50 year experience in multi-steps organic synthesis, PCAS makes available a broad range of processes and chemistries as well as biocatalysis technology solutions and polymers knowledge.
|

